Genedrive PLC
LSE:GDR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Genedrive PLC
Free Cash Flow
Genedrive PLC
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Genedrive PLC
LSE:GDR
|
Free Cash Flow
-£3.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
|
|
Oxford Biodynamics PLC
LSE:OBD
|
Free Cash Flow
-£7.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Free Cash Flow
-£116.3m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Free Cash Flow
-£4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Free Cash Flow
-£1.2m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Free Cash Flow
-£15.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-22%
|
|
Genedrive PLC
Glance View
Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. The Company’s Genedrive device is a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company’s commercial products include Genedrive MT-RNR1, Genedrive BioPlex, Genedrive HCV ID Kit and Genedrive 96 SARS-CoV-2 Ki. Genedrive MT-RNR1 is a commercial test for antibiotic induced hearing loss. Genedrive BioPlex is developed for the determination of military biothreats from pathogens. Genedrive HCV ID Kit is effective in the diagnosis of Hepatitis C Virus (HCV) infection in resource limited settings. Genedrive 96 SARS-CoV-2 Ki is a plate format of a COVID-19 molecular test for high throughput use, which detects all known variants of COVID-19.
See Also
What is Genedrive PLC's Free Cash Flow?
Free Cash Flow
-3.9m
GBP
Based on the financial report for Dec 31, 2025, Genedrive PLC's Free Cash Flow amounts to -3.9m GBP.
What is Genedrive PLC's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
1%
Over the last year, the Free Cash Flow growth was 13%. The average annual Free Cash Flow growth rates for Genedrive PLC have been 2% over the past three years , 9% over the past five years , and 1% over the past ten years .
